Comparison

FSH beta [INN-hFSH-60]

Item no. 20-272-190363
Manufacturer GENWAY
Amount 0.25 mg
Category
Type Antibody
Applications IHC, ELISA
Clone INN-hFSH-60
Specific against other
ECLASS 10.1 32160702
ECLASS 11.0 32160702
UNSPSC 12352203
Alias GWB-CD2081
Similar products 20-272-190363
Available
Genway ID:
GWB-CD2081
Clone:
INN-hFSH-60
Isotype:
IgG1
Immunogen:
Full length native protein (purified) (Human).
Antigen Species:
Human
Specificity:
This product shows strong reactions with hFSH and beta-hFSH. There is no cross-reactivity with hTSH hLH hCG alpha-hCG or alpha-hFSH. The recognition site is located near the alpha 1 binding site on the hFSH molecule. It is not compatible with other anti-hFSH-beta antibodies.
Positive Control:
Pituitary Gland
Target:
FSH beta
Concentration:
1 mg/ml Storage
Buffer:
Phosphate-buffered saline pH 7. 4 containing 0. 09% sodium azide
Application Note:
For ELISA: Use at an assay dependent dilution. For IHC-Fr: Use at an assay dependent dilution. For IHC-P: Use at an assay dependent dilution. Not tested in other applications. Optimal dilutions/concentrations should be determined by the researcher. Follicle-stimulating hormone enables ovarian folliculogenesis to the antral follicle stage and is essential for Sertoli cell proliferation and maintenance of sperm quality in the testis. Members of the pituitary glycoprotein hormone family of which FSH is one consist of a shared alpha chain and a beta chain encoded by a separate gene. The FSH beta gene encodes the beta subunit of follicle-stimulating hormone.
Function:
Stimulates development of follicle and spermatogenesis in the reproductive organs.
Subunit:
Heterodimer of a common alpha chain and a unique beta chain which confers biological specificity to thyrotropin lutropin follitropin and gonadotropin.
Subcellular Location:
Secreted.
Disease:
Defects in FSHB are a cause of isolated follicle-stimulating hormone deficiency (IFSHD) [MIM:229070]. Selective follicle-stimulating hormone deficiency is an uncommon cause of infertility producing amenorrhea and hypogonadism in women and oligo or azoospermia with normal testosterone levels in normally virilised men. Pharmaceutical: Available under the names Gonal-F or Metrodin HP (Serono) and Puregon (Organon). Used in the treatment of infertility in women with proven hypopituitarism or who have not responded to clomifene; or in superovulation treatment for assisted conception (such as in vitro fertilization). Metrodin HP is also used in the treatment of hypogonadotrophic hypogonadism in men for the stimulation of spermatogenesis.
Similarity:
Belongs to the glycoprotein hormones subunit beta family.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 0.25 mg
Available: In stock
available

Delivery expected until 9/11/2025 

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close